Scientist 2
A-Alpha Bio
Scientist 2
A-Alpha Bio
Biologics discovery via high-throughput affinity screening
A-Alpha Bio is an early-stage, rapidlygrowing biotechnology platform companyheadquartered in Seattle, WA.We are focused on building the foundational data layer for AI-driven protein engineering.Weprovide biopharma companies and model builders with access to ground truth experimental datasets, including affinity and structure, for training, benchmarking and validating AI protein models.In parallel, we apply our data and models directly with select partners to engineer next-generation dual-specific and molecular glue therapeutics, and to discover and optimize differentiated biologics.
A-Alpha Bio is headquartered in Seattle, WA, but remote applicants are welcome to apply. Candidates must reside in the United States.
Starting Salary Range: $139,000 - $175,000 annually
Exemption Status: Exempt
Location Expectations: Remote-Eligible (expected travel to Seattle HQ once per quarter)
Reporting To: Director, Applied Machine Learning
Role Description
A-Alpha Bio is seeking a Scientist II to join our Applied Machine Learning team in turning large-scale protein interaction data into insights and models that advance antibody and protein engineering. In this role, you’ll lead computational work for both internal research and external collaborations, from defining scientific questions and analysis plans to developing models and communicating results. Working with AlphaSeq datasets, you’ll connect experimental measurements with protein sequence and structural information to understand binding, evaluate computational design methods, and guide future experiments. Success in this role will depend on ability to state assumptions, clearly define goals and objectives, and explain your procedures thoughtfully.
Key Responsibilities
Qualifications & Experience
Required
Preferred
In 2018, A-Alpha Bio spun out of the University of Washington’s Institute for Protein Design and Center for Synthetic Biology – both communities filled with brilliant and highly entrepreneurial scientists. Since the company’s inception, we have built and scaled AlphaSeq, our high-throughput platform for quantitatively measuring protein-protein interactions at unprecedented scale. What began as a technology for generating large, standardized affinity datasets has grown into a broader data engine for AI-driven protein engineering. New members of the team should expect a fast-paced, highly dynamic, and interdisciplinary work environment. We are building a diverse, meritocratic, and supportive team that shares our values of speaking the truth, shooting for the moon, taking the reins, playing for the team, and improving the world.
A-Alpha Bio is headquartered in a custom designed lab and office space in downtown Seattle’s Belltown neighborhood. We are fortunate to be situated in a region that is renowned for its premier outdoor activities, including hiking, biking, climbing, skiing, kayaking, sailing, and more. At A-Alpha, you’ll find many who love the outdoors, but also gamers, amateur chefs, explorers, sports fans, bakers, crafters, photographers, brewers, jetsetters, animal lovers, and artists. Whatever your passions, you belong at A-Alpha Bio!
Biologics discovery via high-throughput affinity screening
A-Alpha Bio helps drug developers accelerate discovery of biologics, which are therapeutic proteins. Its platform rapidly and quantitatively measures millions of protein–protein binding affinities, enabling simultaneous characterization of how a library of proteins binds to many targets. This allows screening antagonists across full interaction networks and identifying biologics with specificity to multiple targets. Revenue comes from service contracts, licenses, and collaborative partnerships with pharmaceutical and biotech firms. The company differentiates itself by providing a scalable, quantitative binding-measurement platform that can profile binding across large target networks, supporting fast, targeted discovery. Its goal is to advance drug discovery by delivering high-precision binding data to enable the design of specific, effective biologics.
Explore more opportunities at A-Alpha Bio